Ionis Pharmaceuticals | IONS - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celltrion KRW 78.68B 25.51B 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
Omeros USD 8.84M 4.42M 2025-06
OPKO Health USD 44.18M 3.07M 2026-03
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pfizer USD 4.51B 734M 2026-03
Pharma Mar EUR 43.83M 10.51M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tilray USD 114.5M 3.69M 2025-09
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03